These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 9179085
1. Comparison of Neoral and Sandimmune cyclosporine for induction of immunosuppression after heart transplantation. Carrier M, White M, Pellerin M, Pelletier GB, Pelletier LC. Can J Cardiol; 1997 May; 13(5):469-73. PubMed ID: 9179085 [Abstract] [Full Text] [Related]
2. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation]. Roy A, Grant DR, Kneteman NM, Tchervenkov JI, Levy GA, Tan A, Hendricks L. Ann Chir; 1998 May; 52(8):716-21. PubMed ID: 9846420 [Abstract] [Full Text] [Related]
3. Induction of immunosuppression with rabbit antithymocyte globulin: five-year experience in cardiac transplantation. Carrier M, Pelletier GB, Cartier R, Leclerc Y, Robitaille D, Pelletier LC. Can J Cardiol; 1993 Mar; 9(2):171-6. PubMed ID: 8490788 [Abstract] [Full Text] [Related]
4. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up. Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K. Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400 [Abstract] [Full Text] [Related]
5. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH. Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413 [Abstract] [Full Text] [Related]
6. Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients. Cantarovich M, Besner JG, Fitchett DH, Latter DA. Clin Transplant; 1997 Oct; 11(5 Pt 1):399-405. PubMed ID: 9361930 [Abstract] [Full Text] [Related]
7. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients. White M, Pelletier GB, Tan A, Jesina C, Carrier M. J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770 [Abstract] [Full Text] [Related]
8. Effect of pentoxifylline on renal toxicity of cyclosporine: results of a clinical trial after heart transplantation. Carrier M, Pelletier GB, White M, Bois D, Pelletier LC. J Heart Lung Transplant; 1996 Dec; 15(12):1179-83. PubMed ID: 8981202 [Abstract] [Full Text] [Related]
9. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients. Câmara NO, Dias MF, Pacheco-Silva A. Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825 [Abstract] [Full Text] [Related]
12. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone. Barnhart GR, Goldman MH, Hastillo A, Szentpetery S, Wolfgang T, Thompson J, Mohanakumar T, Katz MR, Rider S, Hanrahan J. J Heart Transplant; 1985 Feb; 4(4):381-4. PubMed ID: 3916511 [Abstract] [Full Text] [Related]
13. Comparison of generic cyclosporine microemulsion versus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring. Sharma A, Shekhar C, Heer M, Minz M. Transplant Proc; 2006 Sep; 38(7):2051-3. PubMed ID: 16979996 [Abstract] [Full Text] [Related]
14. Comparison of cyclosporine and tacrolimus in combination with rabbit antithymocyte immunoglobulins as induction therapy in cardiac transplantation. Jacques F, Carrier M, Pelletier GB, Racine N, White M, Perrault LP, Pellerin M. Transplant Proc; 2009 Oct; 41(8):3337-41. PubMed ID: 19857745 [Abstract] [Full Text] [Related]
15. Immunosuppression in live-related donor renal transplantation. Iman A, Rao M, Juneja R, Jacob CK. Natl Med J India; 2001 Oct; 14(2):75-80. PubMed ID: 11396322 [Abstract] [Full Text] [Related]
16. A pharmacoeconomic analysis of Neoral without intravenous cyclosporine in liver transplantation in Canada. Hemming AW, Cattral MS, Greig PD, Meisner J, Turcotte L, Lilly LB, Levy GA. Clin Transplant; 1998 Oct; 12(5):425-9. PubMed ID: 9787952 [Abstract] [Full Text] [Related]
17. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression. Hernández D, Miquel R, Porrini E, Fernández A, González-Posada JM, Hortal L, Checa MD, Rodríguez A, García JJ, Rufino M, Torres A. Transplantation; 2007 Sep 27; 84(6):706-14. PubMed ID: 17893603 [Abstract] [Full Text] [Related]
18. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M. J Heart Lung Transplant; 1997 Oct 27; 16(10):1001-10. PubMed ID: 9361242 [Abstract] [Full Text] [Related]
19. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients? Gaspari F, Perico N, Pisoni R, Anedda MF, Signorini O, Caruso R, Gotti E, Remuzzi G. Clin Transplant; 1998 Oct 27; 12(5):379-90. PubMed ID: 9787945 [Abstract] [Full Text] [Related]
20. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ, Rossi AF, Courtney M, Gelb BD. J Heart Lung Transplant; 1998 Dec 27; 17(12):1195-200. PubMed ID: 9883760 [Abstract] [Full Text] [Related] Page: [Next] [New Search]